The destruction of insulin-producing β-cells is the main pathophysiological feature of T1DM. Cell and gene therapy has always been thought to be able to recover eventually β-cell function, the ultimate means to cure diabetes. Ace Metabolism can provide researchers engaged in cell and gene therapy of diabetes with more efficient function analysis and overall therapy services.
Cell Therapy of T1DM Cell therapy mainly includes tumor cell immunotherapy and stem cell therapy. Islet cells can be generated from human pluripotent stem cells (hPSC) including induced pluripotent stem cell (iPSC) cells or embryonic stem cells (ESC) for the treatment of diabetes. It is transplanted into the body through special transplantation techniques to replace those normal or abnormally dead β-cells. Learn more：T1DM therapy development services